您当前的位置:
首页 >
文章列表页 >
Perioperative factors associated with prognosis of patients after radical resection of pancreatic cancer: a retrospective analysis
更新时间:2026-01-27
    • Perioperative factors associated with prognosis of patients after radical resection of pancreatic cancer: a retrospective analysis

    • China Oncology   Vol. 29, Issue 7, Pages: 521-527(2019)
    • DOI:10.19401/j.cnki.1007-3639.2019.07.007    

      CLC: R735.9
    • Published Online:12 July 2019

      Published:12 July 2019

    移动端阅览

  • 朱序勤, 贾淞淋, 祁 洁, et al. Perioperative factors associated with prognosis of patients after radical resection of pancreatic cancer: a retrospective analysis[J]. China Oncology, 2019, 29(7): 521-527. DOI: 10.19401/j.cnki.1007-3639.2019.07.007.

  •  
  •  
icon
试读结束,您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束,您可以通过登录账户,到个人中心,购买VIP会员阅读全文。
已是VIP会员?
去登录 >

0

Views

3404

下载量

2

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

An exploratory study of INPP4B, a biomarker of gemcitabine chemoresistance in pancreatic cancer
Clinicopathologic features of SMARCA4-deficient pulmonary malignant tumor with an emphasis on the prognosis
Treatment strategies and prognostic analysis of 87 patients with salivary duct carcinoma: a retrospective cohort study
Impact of radiation-induced lymphopenia on prognosis in patients with limited-stage small cell lung cancer: a cohort study
MITF expression in acral melanoma tissues and its association with clinical, pathological characteristics and prognosis

Related Author

Jiaqiang REN
Shuai WU
Tong SU
Jie LI
Liang HAN
Zheng WU
CHANG Kesheng
SHAO Jin

Related Institution

Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiao Tong University
School of Public Health, Xi’an Jiao Tong University Health Science Center
Department of Pathology, Wuxi Second People’s Hospital
Department of Pathology, Affiliated Hospital of Nantong University
Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Malignant Tumors
0